<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Both Type 1 and Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> can lead to debilitating microvascular complications such as <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, <z:hpo ids='HP_0000112'>nephropathy</z:hpo> and <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e>, as well as macrovascular complications such as <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> including <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0271672" disease_type="Disease or Syndrome" abbrv="">Diabetic complications</z:e> have been attributed to several contributing factors such as <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, <z:hpo ids='HP_0003077'>hyperlipidemia</z:hpo>, advanced glycation end products, growth factors, and inflammatory cytokines/chemokines </plain></SENT>
<SENT sid="2" pm="."><plain>However, current therapies are not fully efficacious and hence there is an imperative need for a better understanding of the molecular mechanisms underlying <z:e sem="disease" ids="C0271672" disease_type="Disease or Syndrome" abbrv="">diabetic complications</z:e> in order to identify newer therapeutic targets </plain></SENT>
<SENT sid="3" pm="."><plain>microRNAs (miRNAs) are short non-coding <z:chebi fb="40" ids="33697">RNAs</z:chebi> that repress target gene expression via post-transcriptional mechanisms </plain></SENT>
<SENT sid="4" pm="."><plain>Emerging evidence shows that they have diverse cellular and biological functions and play key roles in several diseases </plain></SENT>
<SENT sid="5" pm="."><plain>In this review, we explore the role of miRNAs in the pathology of <z:e sem="disease" ids="C0271672" disease_type="Disease or Syndrome" abbrv="">diabetic complications</z:e> and also discuss the potential use of miRNAs as novel diagnostic and therapeutic targets for <z:e sem="disease" ids="C0271672" disease_type="Disease or Syndrome" abbrv="">diabetic complications</z:e> </plain></SENT>
</text></document>